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Toxocariasis  is  a helminth  zoonosis  caused  by infection  with  the larvae  of  Toxocara  spp.
ascarid  worms.  Only  two species,  Toxocara  canis and  Toxocara  cati,  are  recognised  as
causative  agents  of  human  disease.  The  best choice  for  serodiagnosis  of the  generalised
forms  of  toxocariasis,  visceral  larva  migrans  (VLM)  or  covert  toxocariasis,  relies  upon  the
initial use of  TES-ELISA,  after  which  any  positive  result  should  subsequently  be  tested  by
Western blotting  (WB).  Covert  toxocariasis  is  mostly  a benign  infection,  so  a large  major-
ity of  infected  subjects  are asymptomatic  or have  very  few  symptoms  and  therefore  go
undiagnosed.  In this  form,  this  helminthosis  is often  self-limiting,  leaving  residual  speciﬁc
antibodies.  A  positive  serodiagnosis  caused  by  residual  antibodies  that  do not  have  any
diagnostic  signiﬁcance  can  be associated  with  any  infectious  or  non-infectious  disease.  If
separated from  the  ongoing  clinical  and  laboratory  context,  such  a positive  result  has  no
diagnostic  value  and should  be only  taken  into  account  after  the  possible  etiologies  of any
observed syndromes  have  been  ruled  out.  Unlike  the  methods  used  for the  immunodi-
agnosis  of  bacterial,  viral  or protozoal  (toxoplasmosis)  infections,  it is not  possible  with
toxocariasis  to assess  the age  of  the presence  of  speciﬁc  IgG  using  the  levels  of speciﬁc  IgM
because IgM  antibodies  can  be found  throughout  the  course  of  helminthiasis.  The  detection
of other  classes  of  immunoglobulins,  namely  IgE and  IgA, the  subclasses,  namely  IgG4 or
circulating  Ag  was  proven  to be unable  to discriminate  between  active  and self-cured  gen-
eralised  toxocaral  infections.  Currently,  the diagnosis  of  an active  covert  toxocariasis  relies
upon indirect  arguments,  e.g., the presence  of  otherwise  unexplained  symptoms  along  with
blood eosinophilia  and/or  elevated  levels  of  eosinophil  cationic  protein  (ECP).  This  situation
is far  from  ideal  and  more  research  should  be carried  out to  solve  this  difﬁcult  problem.. IntroductionToxocariasis is a helminthic zoonosis caused by infec-
ion  with the larvae of Toxocara spp. ascarid worms.
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recognised as causative agents of human disease. The
adults of both species parasitise the small intestines of their
deﬁnitive hosts, canids and felids, respectively (Miyazaki,
1991). In the past, it was assumed that T. canis was the main
cause  of Toxocara spp. related disease. Although there is
evidence  to support this position, there is now substantial
evidence that humans can also be infected by T. cati lar-
vae,  and this infection would similarly elicit visceral larva
Open access under CC BY license.migrans (VLM) and ocular larva migrans (OLM) syndromes
(Fisher, 2003).
The  ﬁrst report of T. canis larvae in hosts other than
dogs was made by Ransom and Foster in 1920 (Barriga,
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1988). In 1952, Beaver et al. published three cases of chil-
dren  presenting with high blood eosinophilia associated
with chronic granulomatous lesions of the liver (Beaver
et  al., 1952). They identiﬁed the larvae found in the liver
as  belonging to T. canis species and termed this novel dis-
ease  “visceral larva migrans”. Beaver later gave a restrictive
interpretation of this term in which humans played the
role  of paratenic host (Beaver, 1956). According to this
deﬁnition, toxocariasis no longer could be considered as a
parasitological dead-end (Harant, 1962) but Beaver’s state-
ment  implied that other Toxocara species could cause this
zoonosis.
2.  Epidemiology
Human most frequently become infected by ingest-
ing embryonated eggs present in nearby soil. Toxocariasis
is primarily a telluric zoonosis and is a saprozoonosis
according to the WHO  classiﬁcation system (WHO, 1979).
Along  with this telluric transmission route, there is also
a  foodborne route involving larvae present in the tissues
of  paratenic hosts that are eaten by humans. The litera-
ture  reports several cases of toxocariasis resulting from
the  consumption of raw or undercooked meat or offal from
birds  or mammals (Akao and Ohta, 2007; Choi et al., 2008;
Hoffmeister et al., 2007; Morimatsu et al., 2006; Salem and
Schantz,  1992; Sturchler et al., 1990; Taira et al., 2004).
The  results of epidemiological surveys have shown that
human toxocariasis is one of the most common helminthi-
ases in the world. In the Western countries, such as those
of  the G8, the seroprevalence varies between 2% and 5% in
urban  areas, reaches 15%–20% in semi-rural zones such as
residential outskirts of large cities, and peaks at 35%–42%
in  rural areas (Magnaval et al., 2001b). Factors that have
been  associated with an increased rate include a low
socioeconomic level and poor environmental hygiene (Cilla
et  al., 1996), which are possibly exacerbated by wet and
warm  climates, such as the climate found in tropical areas
(Magnaval et al., 1994; Thompson et al., 1986).
3. Pathophysiology
Human toxocariasis features an exclusively larval para-
sitism,  since adult worms are never present in the human
digestive tract, apart from exceptional cases (Eberhard
and Alfano, 1998). In the duodenum, larvae hatched from
embryonated eggs (telluric contamination) or released
by  the digestion of the tissues of paratenic hosts (food-
borne contamination) enter the somatic cycle. When the
cycle  is complete, larvae migrate for a variable period
of  time in the human body. Once arrested in tissues
or organs where immune and/or phagocytic cells are
abundant, they can be trapped inside eosinophilic granu-
lomas  where they will degenerate (Marty, 2000; Parsons
and  Grieve, 1990). Larvae continuously release approxi-
matively 2 ng/larva/day of soluble glycoprotein antigens
termed “excretory-secretory” (ES Ag), which are almost
completely absent in the somatic antigenic panel of larvae
and  adults (Fernando et al., 1970). A part of the ES Ag has
an  internal origin and is secreted by the larva esophageal
gland and excretory column (Page et al., 1992a). The otherrasitology 193 (2013) 327– 336
part  is made up of glycoproteins that are released from the
larval  outer epicuticular layer (Page et al., 1992b), which
is  renewed continuously and rapidly: the turnover rate is
50%  within 1 h and 80% within 48 h (Maizels et al., 1984).
It  is likely that ES Ag release is involved in the survival of
the  larvae inside the paratenic host, which preferentially
mounts an immunological response against the soluble Ag
rather  than against the somatic Ag that are exposed only
during  larval destruction. ES Ag contain a potent allergenic
fraction (Sugane and Oshima, 1983) that was  later iden-
tiﬁed  as TBA-1 (Yahiro et al., 1998). This ﬁnding would
explain the frequency of allergic symptoms in toxocari-
asis patients (Glickman et al., 1987), especially in atopic
subjects (Buijs et al., 1997; Gonzalez-Quintela et al., 2006).
The  high immunogenicity and allergenicity of ES Ag suggest
that  most cases of toxocariasis would be caused by tiny
larval  inocula. In 1959, a volunteer ingested 100 embry-
onated eggs of T. canis following which he presented with
a  permanent cough that lasted several months. His blood
eosinophilia reached 13,500 cells/mm3 on day 30 post-
inoculation and still was 6150 cells/mm3 four and a half
months later (Chaudhuri and Saha, 1959).
4. Clinical picture
A  general agreement now exists concerning the
nosology of human toxocariasis, which includes several
syndromes (Despommier, 2003; Magnaval et al., 2001b;
Schantz, 1989; Smith et al., 2009). However, it should be
noted  that most infections are clinically asymptomatic.
4.1. Generalised forms
4.1.1.  Major syndrome
The  so-called VLM syndrome such as deﬁned by Beaver
(Beaver, 1956), is caused by ingesting very large amounts of
Toxocara  spp. embryonated eggs and is generally reported
in  children living in poor socioeconomic conditions or
in  individuals suffering of mental retardation or severe
psychiatric disorders, all of whom present with pica
or  geophagia. VLM syndrome is uncommon in Western
countries. The clinical picture comprises an impairment
of the general status that includes weight loss and fever
along  with asthmatic cough, wheezing, generalised lym-
phadenopathy, hepatomegaly and often Löfﬂer’s inﬁltrates
on  a chest X-ray photographs (Beaver et al., 1952; Ehrhard
and  Kernbaum, 1979).
4.1.2.  Minor syndromes
The  discrepancy between the high seroprevalence
found in most countries and the low number of VLM cases,
of  which only 970 had been recorded between 1952 and
1978  (Ehrhard and Kernbaum, 1979) suggested the exist-
ence  of other forms of the disease. In the mid-1980s, two
studies  were carried out simultaneously in French adults
(Glickman et al., 1987) and Irish children (Taylor et al.,
1988). They demonstrated that human toxocariasis was
not  a rare condition and generally assumed the features
of  a syndrome that included chronic weakness, digestive
pain, various allergic signs – often conjunctival or cuta-
neous, such as itchy rash or pruritus – diffuse myalgias,
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ngioneurotic edema, irritation cough and, in children,
leeping and behavior disturbances. This clinical form was
alled  “covert toxocariasis” ﬁrst in Ireland and then in
he  English-speaking world and “common toxocariasis” in
rance.
.2.  Compartmentalised forms
.2.1. Ocular toxocariasis
Ocular  toxocariasis was described prior to VLM (Wilder,
950). Usually the disease occurs in toddlers, young chil-
ren,  teenagers or young adults and is generally unilateral.
he presence of a single larva in the eye wall or in close
roximity induces chronic inﬂammation and the immuno-
ogical response to the ES Ag released in a rather enclosed
rea plays a crucial role. The pathological outcome is ante-
ior  uveitis or, more often, posterior uveitis along with
yalitis and chorioretinitis. The opaciﬁcation of the vitre-
us  humor can be accompanied by deposits of immune
omplexes, often in the periphery (“snowballs”), and by
he  development of ﬁbrous traction bands that result in
etinal  detachment. If the larva is trapped in the eye mem-
ranes by the inﬂammatory reaction, a retinal granuloma
an develop, often at the posterior pole. When large, it can
ause  a bulging at the posterior pole which resembles a
etinoblastoma (Balmer and Munier, 2007). The most com-
on  ﬁrst sign is vision loss in the affected eye that increases
uickly within days or a few weeks. Many patients have a
ubclinical infection and are diagnosed only during a rou-
ine  eye examination (Good et al., 2004).
.3. Neurological toxocariasis
Infection  of the central nervous system (CNS) by
oxocara spp. larvae causes non-speciﬁc illnesses such
s  meningitis, meningoencephalitis or transverse myeli-
is  (Eberhardt et al., 2005; Vidal et al., 2003, Caldera
t al., 2012). Thus, frequently the relationship between
he observed symptoms and toxocariasis remains unclear
Magnaval et al., 1997). This form of the zoonosis appears
o  be rare because a rather recent review of the litera-
ure reported only 40 cases of neurological toxocariasis
Eberhardt et al., 2005). The involvement of toxocariasis
s a primary cause of epilepsy is still controversial.
. Laboratory diagnosis
.1.  Non-speciﬁc tests
.1.1.  Blood count
In  VLM syndrome, blood counts always showed the
resence of blood eosinophilia, which was usually marked
Altcheh et al., 2003) and was sometimes massive: approx-
mately 10,000 cells/mm3 (Ehrhard and Kernbaum, 1979;
assmann et al., 2007). In common or covert toxocari-
sis, blood eosinophilia values are lower on average:
pproximately 1500 cells/mm3 (Glickman et al., 1987). This
bnormality can be absent (Magnaval et al., 1994; Taylor
t  al., 1988) particularly in patients with chronic skin
llergy symptoms (Gavignet et al., 2008). In ocular toxo-
ariasis, blood eosinophilia levels are usually within therasitology 193 (2013) 327– 336 329
normal  range because the disease is usually caused by a
single  larva (Gillespie et al., 1993b; Glickman and Schantz,
1981). However, when the eye involvement is due to a
larval  migration occurring during a generalised infection,
blood eosinophilia is present (Magnaval et al., 2002). No
general  conclusions could be reached about neurological
toxocariasis given the very low incidence of this form.
5.1.2.  Cytological examination of other ﬂuids
The presence of Toxocara spp. larvae in the CNS was gen-
erally  accompanied by eosinophilia and pleocytosis in the
cerebrospinal ﬂuid (CSF) (Vidal et al., 2003). The presence
of  eosinophils was  also reported in the aqueous or vitreous
humor during ocular toxocariasis (Liotet et al., 1992), but
the  very small volume of this type of sample makes the test
unusable  in practice.
5.1.3.  Total serum IgE levels
The  phenomenon of a chronic increase in total serum
IgE levels during a worm infection was  ﬁrst described
in 1968 in Ethiopian children with ascariasis (Johansson
et al., 1968) and results from a mechanism that remains
unclear. This elevation was later found in most helminthi-
ases, including toxocariasis (Hogarth-Scott et al., 1969). In
the  common form of toxocariasis, 79% of patients presented
with  an increased level of total serum IgE, (Magnaval et al.,
1994),  and the mean value was approximately 850 kIU/L
(Glickman et al., 1987).
5.1.4.  Laboratory markers of inﬂammation
Laboratory hallmarks of inﬂammation were frequently
reported during the course of VLM syndrome (Ehrhard and
Kernbaum, 1979). In common/covert toxocariasis, these
abnormalities appeared to be rather uncommon because
only  11% of patients with this form of the disease exhibited
an  elevated sedimentation rate (Magnaval et al., 1994).
5.2.  Direct optical diagnosis
A  diagnosis of toxocariasis is only conﬁrmed by visual
methods (the “gold standard”). Gross examination can
identify a larva found, e.g., in the CSF (Eberhardt et al.,
2005; Vidal et al., 2003) or in ocular ﬂuids (de Souza and
Nakashima, 1995). Live larvae are highly motile in liquid
media. Microscopic examination of biopsies or organ frag-
ments  can discover larval sections or debris (Kirchner and
Altmann, 1987; Marty, 2000). T. canis larvae, if undamaged,
display the morphological characteristics of larval nema-
todes.  On average, they are 400 m in length and 18–20 m
in  breadth. The edges are parallel to the bulk of the body,
so  the larvae appear squat. The length of the esophagus is
about  one-third of the total body length (Nichols, 1956). On
pathological examinations, the cuticle presents two char-
acteristic lateral alae (Marty, 2000). T. cati larvae have a
similar  morphology (Nichols, 1956).
5.3. ImmunodiagnosisDevelopment of serological methods was  prompted
by the difﬁculties and uncertainties of direct visual
diagnosis. By the late 1950s, as part of the scientiﬁc
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aying thFig. 1. Immunoelectrophoresis displ
movement during which novel immunological techniques
were applied in parasitology, Kagan reported a test using
Ascaris  lumbricoides or Ascaris suum extracts for toxocari-
asis  serodiagnosis (Kagan, 1957, 1958). This ﬁrst attempt
was  followed by many others that relied primarily upon
the  use of sections or soluble extracts from adult worms
of  T. canis (homologous antigen) or A. lumbricoides or A.
suum  (heterologous antigens). All of the methods proved to
be  affected by a severe lack of speciﬁcity (Glickman et al.,
1986).  This shortcoming originated in the high complex-
ity  of the antigenic structure of helminths, which elicited
a  variable level of cross-reactivity between taxonomically
distant parasites. This point was analysed and then the
“antigenic panel” concept was highlighted by the studies
carried out at the Pasteur Institute in Lille, France (Biguet
et  al., 1965). Moreover, Pasteur’s researchers working with
Schistosoma spp. demonstrated that the antigenic structure
of  a given worm contained speciﬁc fractions and that some
of  them were found only at certain developmental stages
(Capron et al., 1965). Fernando et al. made similar ﬁndings
concerning T. canis (Fernando et al., 1970). These authors
used  Ouchterlony’s method (agar double diffusion), and
they  tested extracts of T. canis, A. lumbricoides or Ascaridia
galli embryonated eggs or adults worms against sera from
macaques that had been experimentally infected with T.
canis  larvae. The simian sera recognised ﬁve fractions in the
T.  canis egg extracts that were absent from the adult worm
antigens. Therefore, these results suggested that methods
using extracts of Toxocara spp. adults, which were already
known to display a speciﬁcity problem, would also lack
sensitivity.
A  ﬁrst improvement came from the use of heterologous
egg extracts. In 1973, Niel et al. used immunoelectrophore-
sis (IEP) to test various antigenic extracts from several
Ascaris and Toxocara species against sera from patients pre-
senting  with chronic blood eosinophilia (Niel et al., 1973).
When  extracts from female A. suum genital tracts were
used, these authors observed a characteristic precipitat-
ing line that they designated as “major”. Subsequently,
Magnaval et al. (1986) carried out further investigations
with a similar extract. They demonstrated that the ovular
fraction involved in the major precipitating band (Fig. 1)
was  present in T. canis ES Ag but was absent from A. suum
coelomic ﬂuid or T. canis somatic extracts. This typical band
was  only observed when sera from a macaque that had
been  orally infected with T. canis embryonated eggs or
from  eosinophilic patients who displayed a clinical syn-
drome  consistent with toxocaral disease were tested by
IEP.  Serum samples from patients with known helminthi-
ases other than toxocariasis did not react (Magnaval et al.,e typical “major” precipitation band.
1986).  This IEP technique had an excellent speciﬁcity but
exhibited a low sensitivity because precipitation tests are
known  to require high levels of speciﬁc antibodies to turn
positive. In the mid-1970s, Cypess et al. (1977) reported
a  test that combined ELISA, a novel assay described in
1971  (Engvall and Perlmann, 1971), with extracts of T. canis
embryonated eggs as antigen. To avoid the cross-reaction
shortcoming, the sera were ﬁrst adsorbed on a powdered
extract of A. suum adults. The subsequent assessment of
this  method found a sensitivity of 78% and a speciﬁcity of
92.3%  (Glickman et al., 1978). With these results, a con-
venient solution to the issue of toxocariasis serodiagnosis
was  offered for the ﬁrst time. However, the adsorption
step using A. suum powder made this diagnostic proce-
dure rather cumbersome. Moreover, a sensitivity of 78%
suggested that low-burden infections could be missed.
In  1976, a decisive step forward was made when de
Savigny published a method for maintaining T. canis lar-
vae  in culture (de Savigny, 1975) and T. canis ES Ag (TES
Ag)  became available on a large scale. This author went on
to  describe an ELISA using TES Ag (de Savigny et al., 1979),
thus  bringing the immunodiagnosis of toxocariasis into the
modern  era.
5.3.1.  Production of TES Ag
All laboratories that carry out the “cultivation” of T.
canis  larvae use variants of de Savigny’s original method.
Brieﬂy, the female worms are collected from puppies after
deworming with piperazine, an anthelmintic drug that
does  not kill eggs, or after necropsy. Female worms are
washed with tap water and then dissected. The geni-
tal  tracts undergo a controlled artiﬁcial digestion in a
pepsin-HCl mixture to remove the surrounding tissues.
The  collected eggs are distributed in glass tubes that are
plugged with cotton wool and contain a 0.9% NaCl solution
supplemented with 1% formalin. The tubes are incubated
at  37 ◦C in a stirring water bath for 2–3 weeks. Periodi-
cally, the embryonation level is assessed by microscopic
inspection. When the rate is approximately 50%, the eggs
are  dissected in a Potter’s grinder. Further steps require
a  sterile environment provided by a laminar ﬂow bench.
The  resulting mixture, which contains living and dead lar-
vae  along with eggshell fragments, is diluted in RPMI 1640
medium. Viable larvae are extracted from the crude mix-
ture  using a method similar to the Baermann technique
employed to retrieve Strongyloides stercoralis larvae from
stools.  The larvae are then distributed in ﬂat vials of the type
used  in virology for cell cultures that are ﬁlled with RPMI
1640  medium supplemented with glutamine (Fig. 2). The
ﬁnal  larval concentration is approximately 1000 larvae/mL.
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tig. 2. Virology ﬂask containing Toxocara canis larvae in RPMI 1640
edium.
he vials are incubated at 37 ◦C in a 5% CO2 atmosphere.
nce a week, the vials are tilted at 45 ◦C to allow the
arvae to deposit. The supernatant containing TES Ag is
ollected,  ultracentrifuged and ﬁnally dialysed against dis-
illed  water. The protein concentration is measured and
he  mixture is then aliquoted into special vials and freeze-
ried  under a nitrogen atmosphere. The vials are stored
t  −80 ◦C, and continuously repeated quality assessments
ave demonstrated that this TES Ag stock retained its anti-
enic  properties over a 20-y period.
.3.2. Routine methods and diagnostic strategies
An ELISA detecting IgG antibodies against TES Ag (IgG
ES-ELISA) has become the reference test for toxocari-
sis immunodiagnosis. Currently, several manufacturers
arket kits and claim performance levels that are over-
ll  quite similar (Smith and Noordin, 2006). However, it
hould  be noted that an assessment of only one kit has
een  published (Jacquier et al., 1991). The results were a
ensitivity of 91% and a speciﬁcity of 86%. Examination of
he  technical leaﬂets from other kits showed that manu-
actures often included a reference to this paper, but the
anufacturing process was inevitably different. A con-
omitant assessment of the marketed ELISA kits is therefore
ighly desirable, similar to the assessments that are peri-
dically carried out using dipstick kits for malaria diagnosis
Guthmann et al., 2002).
Jacquier et al. (1991) reported that cross-reactions
ccurred when sera from patients with strongyloidiasis or
richinellosis were tested. These ﬁndings were in agree-
ent  with Lynch et al. (1988) who created an in-house
ES-ELISA in 1988. These authors demonstrated that sera
rom  ascariasis patients induced highly positive results;
herefore the value of TES-ELISA in tropical areas was quite
uestionable. To dampen this cross-reaction phenomenon,
ynch et al. used the method previously described by
ypess et al. (1977): a prior adsorption of the sera on A.
uum  powdered extract (Lynch et al., 1988). The TES-ELISA
peciﬁcity was  drastically enhanced. However, according
o  previous studies (Magnaval et al., 1986; Niel et al., 1973)
ndicating that antigenic fractions were shared between
ES  Ag and A. suum egg extracts, it was feared that the
ensitivity would be decreased. This became obvious when
he  results of seroprevalence surveys in children living inFig. 3. Positive Western-blot result displaying the typical 7-band pattern.
urban tropical areas were compared. Brazilian researchers
found a seroprevalence rate of 8.7% (Teixeira et al., 2006),
whereas their Argentina counterparts who used a Western-
blot  assay on a similar population found that 67.0% of the
results  were positive (Lopez Mde  et al., 2005).
The indisputable speciﬁcity problem of TES-ELISA aris-
ing  when the test was used in possibly multiply parasitised
subjects stressed the need for a more speciﬁc method, with-
out  paying for it through a loss of sensitivity. In the wake
of  the improvement of immunodiagnosis of HIV infection
(Esteban et al., 1985), a Western blotting (WB) procedure
that detected IgG speciﬁc for TES Ag was established in
the  late 1980s by Magnaval et al. (Magnaval et al., 1991).
Tested by WB,  sera from an experimentally infected rabbit
and  from patients presenting with ocular or generalised
toxocariasis displayed a characteristic banding pattern,
including a group of 4 bands in the lower molecular weight
(LMW)  zone at 24, 28, 30 and 35 kDa and a group of 3 bands
in  the higher molecular weight (HMW)  zone at 132, 147
and  200 kDa (Fig. 3). Sera from patients with toxocariasis,
inary Pa
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cystic echinococcosis, hookworm infection, pin-worm
infection, various types of ﬁlariases or schistosomiases,
strongyloidiasis, taeniasis or trichinellosis were negative
or  showed only an incomplete proﬁle, which was  char-
acterised by bands only in the HMW  zone. A detailed
statistical analysis demonstrated that only the antibodies
that reacted with the LMW  antigenic fractions were spe-
ciﬁc  for toxocariasis. Subsequent studies that were carried
out  in animal models, either rabbit (Morales et al., 2002)
or  mouse (Sarimehmetoglu et al., 2001), or in humans
(Roldan and Espinoza, 2009; Zarnowska and Jastrzebska,
1994) also found the previously described banding pat-
tern  comprising seven bands distributed between the LMW
and  HMW  zones and thus conﬁrmed the speciﬁcity of the
antibodies reacting with the LMW  fractions of TES Ag.
Additionally, a later study (Roldan and Espinoza, 2009)
showed that the bands occasionally observed in the zone
ranging from 55 to 65 kDa when certain WB  commercial
kits were used did not correspond to speciﬁc reactions.
Finally, comparative assessment of commercial kits for
TES-ELISA and in-house WB  found a 55% higher sensitivity
for  the latter method (Courtade et al., 1995; Gueglio et al.,
1994).
For  the serodiagnosis of the generalised forms of tox-
ocariasis, VLM or common/covert toxocariasis, the best
choice  relies upon the initial use of TES-ELISA, after which
any  positive result should be subsequently tested by WB.
Moreover, it is necessary to use WB testing on sera dis-
playing optical densities (OD) located in the so-called “gray
zone”,  of which the upper limit is the cut-off value, and
the  lower limit varies according to the manufacturer of
the  TES-ELISA kit. There is great interest in this combined
diagnostic procedure because TES-ELISA provides fast and
relatively  inexpensive negative results, whereas WB check-
ing  of OD values situated in the “gray zone” or over the
cut-off line, dramatically enhances both the sensitivity and
speciﬁcity.
The  only current concern is the diagnostic value of a pos-
itive  result, which is constantly obscured by the presence
of  a more or less elevated seroprevalence rate.
Common/covert toxocariasis is mostly a benign infec-
tion, so a large majority of infected subjects are
asymptomatic or have very few symptoms and go undiag-
nosed. In this form, this helminthiasis is often self-limiting
and leaves residual speciﬁc antibodies. On average, the
duration of a positive TES-ELISA result would be 2.7 years
(Jeanneret, 1991), and over 5 years for WB  (Magnaval
et al., 2001b). A positive serodiagnostic caused by resid-
ual  antibodies that do not have any diagnostic signiﬁcance
can therefore be associated with any infectious or non-
infectious disease. If separated from the ongoing clinical
and  laboratory context, such a positive result has no diag-
nostic  value and should be only taken into account after
the  possible etiologies of the observed syndromes – includ-
ing  blood eosinophilias – have been ruled out. Thus, a
request for toxocariasis serology should always be included
in  an immunodiagnostic panel, the content of which varies
according to the collected epidemiological and clinical
information (Magnaval, 2004).
Immunodiagnosis of ocular and neurological compart-
mentalised forms represents a difﬁcult problem. Therasitology 193 (2013) 327– 336
parasite burden is always tiny and often reduced to one
larva;  thus an immunodiagnostic test carried out on serum
usually  is negative (Eberhardt et al., 2005; Gillespie et al.,
1993b;  Glickman and Schantz, 1981; Vidal et al., 2003).
If  positive, interpretation falls into the quandary caused
by  the possible presence of residual antibodies. For ocu-
lar  toxocariasis, the solution came from the generalisation
of anterior chamber paracentesis (ACP), which made pos-
sible  immunodiagnosis using aqueous humor (AH) in a
TES-ELISA (Benitez del Castillo et al., 1995; de Visser et al.,
2008)  or WB  (Magnaval et al., 2002). Both methods detect
speciﬁc IgG. For neurological toxocariasis, immunodiagno-
sis can be carried out on CSF (Magnaval et al., 1997; Vidal
et  al., 2003). Immunodiagnosis on AH or CSF should be
always coupled with serum testing. If the results are dis-
cordant, namely negative on serum but positive AH or CSF,
this  ﬁnding indicates intraocular or intrathecal synthesis
of  speciﬁc anti-ES Ag IgG. When serum and any aspirated
ﬂuid are simultaneously positive, synthesis of speciﬁc IgG
in  the eye or CNS should be assessed using Reiber’s formula
(Reiber and Felgenhauer, 1987).
Post-treatment follow-up is not possible using detec-
tion of speciﬁc IgG, because the kinetics of this class of
immunoglobulin is very slow, even after a successful treat-
ment  (Bass et al., 1987; Elefant et al., 2006).
6. Diagnostic perspectives
6.1.  Detection of current infections
6.1.1. Eosinophil cationic protein (ECP) levels
Because eosinophil cells accumulate preferentially into
tissues  (Rytomaa, 1960), it was hypothesised that a lack of
blood  eosinophilia did not necessarily indicate the absence
of  eosinophilia elsewhere in the body. ECP and other gran-
ular  cationic proteins are released when eosinophil cells
are  activated. A study was  carried out in our Depart-
ment, in order to assess the usefulness of ECP dosage to
detect  active toxocaral infections (Magnaval et al., 2001a).
Brieﬂy, ECP dosage was carried out in four groups of sub-
jects.  Group 1 comprised 27 apparently healthy subjects
in  whom allergy and helminthiases, including toxocari-
asis, had been ruled out. Group 2 included 23 subjects
who  displayed a positive serodiagnosis for toxocariasis,
but who were fully asymptomatic, or who  presented clin-
ical  symptoms not consistent with toxocariasis. Group 3
was  made of 36 patients presenting with various intesti-
nal  and systemic helminthiases, and Group 4 comprised
110 patients who exhibited clinical and laboratory features
of  common/covert toxocariasis. Mean level of ECP dosage
was  found to be 10.8 g/L in Group 1, 11.2 g/L in Group
2, 76.6 g/L in Group 3, and 42.3 g/L in Group 4. Distri-
bution of the results was studied using Mann–Whitney U
test.  No signiﬁcant difference was found between Group
1  and Group 2, but these groups differed signiﬁcantlythe  levels of ECP were used to assess the presence of a
current active toxocariasis in patients who did not dis-
play  any blood eosinophilia (Magnaval and Glickman,
2006).
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.1.2. Quantiﬁcation of the avidity of speciﬁc IgG
This technique has proven to be useful in toxoplasmo-
is serology to investigate seroconversions occurring in
regnant  women (Bobic et al., 2009; Lachaud et al., 2009).
n  11 Polish children suffering from toxocariasis who were
ollowed  over a 6–12-month period, the level of speciﬁc
gG avidity increased signiﬁcantly in 10 children (Dziemian
t  al., 2008). Further studies are needed to validate this
oncept.
.2.  Improvement of speciﬁcity
.2.1.  Levels of speciﬁc IgG subclasses: TES-ELISA for
gG3/IgG4
It  has been demonstrated in helminthiases such as
chistosomiasis (Li et al., 2001), hydatidosis (Daeki et al.,
000)  or particularly lymphatic ﬁlariasis (Addiss et al.,
995)  that the level of speciﬁc IgG4 synthesis was pro-
ortional to subject’s tolerance to the involved worm and
herefore to the chronicity of infection. A study of speciﬁc
gG4  levels in toxocariasis found a signiﬁcant association
ith the duration of exposure to reinfections (Magnaval
nd Glickman, 2006). An ELISA detecting the IgG4 subclass
peciﬁc for TES Ag was found to have a better speciﬁcity
ut a lower sensitivity than the conventional IgG TES-ELISA
Noordin et al., 2005; Watthanakulpanich et al., 2008).
imilar results have been already observed with various
lariases (Lal and Ottesen, 1988). As far we are aware, the
etection of speciﬁc IgG4 does not have any current routine
se.
.2.2.  Use of recombinant Ag
Although the performance of the TES-ELISA/WB test-
ng  pair is satisfactory with respect to both its sensitivity
nd speciﬁcity, this combined diagnostic process is costly if
ommercial  kits are used and is occasionally cumbersome.
y the mid-1990s, a recombinant Ag corresponding to the
6  kDa fraction of TES Ag was synthesised and tested using
n  ELISA that detects speciﬁc IgG. The results were disap-
ointing because the sensitivity was very low (Gems et al.,
995).  Later, a recombinant 30 kDa Ag was also assessed
sing an ELISA for speciﬁc IgG. A sensitivity of 100% and a
peciﬁcity  of 97.9% were claimed, but only 11 toxocariasis
era had been tested (Yamasaki et al., 2000). More realis-
ic  results, namely 92.3% for the sensitivity and 89.6% for
he  speciﬁcity, came from the further assessment of the
ecombinant 30 kDa Ag after testing 26 positive reference
era using IgG TES-ELISA (Norhaida et al., 2008). In 2009, a
omparison of the diagnostic value of three recombinant Ag
ith  MWs  of 26, 30 and 120 kDa was published. After ELISA
esting  for each of the four IgG subclasses, the best results
ere  observed when IgG4 was tested. The sensitivity cor-
elated  with increased Ag MW (26 kDa < 30 kDa < 120 kDa),
nd  a strictly inverse result was observed for the speciﬁcity
Mohamad et al., 2009).Further assessments are clearly required, but the use of
ecombinant Ag appears to be a very interesting method to
ddress  the increasing difﬁculty in obtaining adult worms
nd  would combine the speciﬁcity and sensitivity of WB
nd  the low cost of TES-ELISA in a single DOT ELISA test.rasitology 193 (2013) 327– 336 333
6.2.3.  Detection of other immunoglobulin isotypes: TES
ELISA  for speciﬁc IgE
As  soon as the early 1980s, the presence of IgE
speciﬁc for TES Ag was established in the sera of tox-
ocariasis patients (Brunello et al., 1983). The results of
immunodiagnostic tests detecting this isotype, either by
radioimmunoassay (Genchi et al., 1986) or by ELISA (Oliver
et  al., 1986), were published, but no practical application
ensued. By the turn of the 1990s, an immunoenzymatic
assay for IgE directed against TES Ag (IgE TES ELISA) was
developed and assessed and then ﬁnally routinely used on
a  very large scale (approximately 2500 tests a year) in the
Department of Parasitology of Toulouse University Hos-
pitals  (Magnaval et al., 1992). Because a part of the Th2
immune response, and not of the Th1 response, was thus
quantiﬁed, the performance of IgE TES-ELISA differed dra-
matically  from the performance of the conventional IgG
TES-ELISA. When a 20 Toxocara spp. units (TU)/L cut-off
was  employed, the speciﬁcity was  89.8%, but the sensitiv-
ity  was only 53.2%. Approximately 20% of patients had a
titer  below 5 UT/L, which indicates the likely absence of
speciﬁc  IgE. Conversely, 8% of subjects presenting with an
atopic  status were found to be positive only by IgE TES-
ELISA. Moreover, signiﬁcant titers of speciﬁc anti-TES Ag
IgE  – over the 20 UT/L cut-off were found only in patients
having a clinical history and the laboratory hallmarks of
allergy  (Magnaval et al., 2006). Similarly to speciﬁc IgG,
speciﬁc IgE is long-standing, so the test is not convenient
for the detection of active toxocaral infection. However,
in  patients displaying a signiﬁcant level of speciﬁc IgE,
the  titer decreased quickly after an effective anthelmintic
therapy was  administered, and IgE TES-ELISA is currently
used in our Department to monitor toxocariasis treat-
ment in atopic subjects (Magnaval, 1995; Magnaval and
Glickman, 2006). Anti-TES Ag IgE were also found in the AH
of  patients who  were investigated for ocular toxocariasis.
In some cases, the intra-ocular titer was greater than the
serum  level, which indicated a local synthesis of speciﬁc IgE
and  therefore toxocaral ocular involvement (Genchi et al.,
1986;  Magnaval et al., 2002).
6.3. Provisional dead-ends
6.3.1.  Detection of circulating Ag
Detection of circulating TES Ag with the goal of diag-
nosing active toxocaral infection was carried out using a
sandwich  ELISA (Gillespie et al., 1993a; Robertson et al.,
1988).  Likely because most patients have a very low lar-
val  burden and also because larvae can be entrapped
and destroyed inside granulomas, the test showed a dis-
appointingly very low sensitivity. This shortcoming was
accompanied by a lack of speciﬁcity, with 10 positive
results among sera from 40 patients with helminthiases
other than toxocariasis (Gillespie et al., 1993a).
6.3.2. Molecular diagnostic methods
Molecular diagnostic methods are hampered by severalfactors that have thus far made the search for Toxocara
spp. DNA inconvenient for the routine diagnosis of human
infection. The ﬁrst factor is, once again, that most forms of
human  toxocariasis are likely caused by tiny inocula and
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the probability of obtaining a tissue sample containing a
larva  appears to be very low. The second point is that the
collection of tissue samples is invasive, which is not accept-
able  for the diagnosis of a usually benign disease from an
ethical  and technical point of view. Research on this topic
did  not go beyond experimentation on animal models (Rai
et  al., 1997). The only prospect could be in the subsequent
identiﬁcation of larval structures found, e.g., in biopsies or
in  organ fragments from surgery or necropsies and in CSF,
but  this approach is not currently used in practice (Ishiwata
et  al., 2004; Caldera et al., 2012).
6.4. Diagnosis of T. cati infection
Various serological methods for the diagnosis of T.
cati  infection have been reported, but only Ouchterlony’s
method has had a published assessment (Petithory and
Beddock, 1997). Initial investigations suggested a high
degree of homology between ES Ag from both species
(Hogarth-Scott et al., 1969). Further studies noted the exist-
ence  of speciﬁc fractions in T. cati ES Ag (Kennedy et al.,
1987),  which could lead to a speciﬁc immunodiagnosis
for feline toxocariasis. Petithory and Beddock (1997) used
Ouchterlony’s double-diffusion technique and ES Ag from
both  T. canis and T. cati larvae to study 274 sera from
patients suspected to have toxocariasis. They reached the
conclusion that one third of the patients exhibiting a pos-
itive  immunodiagnosis might be infected by T. cati larvae.
Conversely, Western blot using T. canis ES Ag seemed
unable to discriminate between the two types of infection.
Since 1990, more than 60,000 WB  tests have been carried
out  in our department. Although some of the WBs  used
sample from patients who had circumstantial evidence of
feline  toxocariasis, a banding pattern different from the
pattern  described above has not been observed so far.
7.  Conclusion
For the immunodiagnosis of human toxocariasis, the
combined use of TES-ELISA followed by WB is the current
option of choice with respect to sensitivity and speci-
ﬁcity. However, the difﬁculty of diagnosing active infection
in  common/covert toxocariasis remains a problem. The
presence of a more or less important rate of residual anti-
bodies  in the general population makes interpretation of
a  positive test difﬁcult, apart from in cases of compar-
timentalised infection. Unlike the methods used for the
immunodiagnosis of bacterial, viral or protozoal (toxo-
plasmosis) infections, it is not possible in toxocariasis to
assess  the age of the presence of speciﬁc IgG using the lev-
els  of speciﬁc IgM because IgM antibodies can be found
throughout the course of helminthiasis (Smith, 1993). The
detection  of other classes of immunoglobulins, namely IgE
(Magnaval  and Glickman, 2006), IgA (Elefant et al., 2006),
the  subclasses, namely IgG4 (Smith and Noordin, 2006)
or  circulating Ag was proven to be unable to discriminate
between active and self-cured generalised toxocaral infec-
tions.  Currently, the diagnosis of an active common/covert
toxocariasis relies upon indirect arguments, e.g., the pres-
ence  of otherwise unexplained symptoms along with blood
eosinophilia and/or elevated levels of ECP.rasitology 193 (2013) 327– 336
This situation is far from ideal and more research should
be  carried out to solve this difﬁcult problem.
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